Substance Abuse
Volume 43, 2022 - Issue 1
Original Research
Sociodemographic differences in quality of treatment to Medicaid enrollees receiving buprenorphine
Rachel K. Landisa George Washington University Trachtenberg School of Public Policy and Public Administration, Washington, District of Columbia, USA;b RAND Corporation, Arlington, Virginia, USACorrespondence[email protected]
https://orcid.org/0000-0002-4618-9430View further author information
, PhD, MPPhttps://orcid.org/0000-0002-4618-9430View further author information, , PhD, , PhD, Adam J. Gordond Program for Addiction Research, Clinical Care, Knowledge and Advocacy (PARCKA), Salt Lake City, Utah, USA;e Department of Internal Medicine, Division of Epidemiology, University of Utah School of Medicine, Salt Lake City, UT, USA;f Informatics, Decision-Enhancement, and Analytic Sciences Center (IDEAS), Veterans Affairs Salt Lake City Health Care System, Salt Lake City, Utah, USAhttps://orcid.org/0000-0002-2453-8871View further author information
, MDhttps://orcid.org/0000-0002-2453-8871View further author information, , PhD, , MD PhD, , PhD, , MS & Bradley D. Steini RAND Corporation, Pittsburgh, Pennsylvania, USA;j Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USAhttps://orcid.org/0000-0003-1544-458XView further author information
, MD PhDhttps://orcid.org/0000-0003-1544-458XView further author information show all